71 related articles for article (PubMed ID: 9371503)
21. Leptin augments recruitment of IRF-1 and CREB to thrombospondin-1 gene promoter in vascular smooth muscle cells in vitro.
Sahu S; Ganguly R; Raman P
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C212-24. PubMed ID: 27281481
[TBL] [Abstract][Full Text] [Related]
22. Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.
Janz A; Sevignani C; Kenyon K; Ngo CV; Thomas-Tikhonenko A
Nucleic Acids Res; 2000 Jun; 28(11):2268-75. PubMed ID: 10871348
[TBL] [Abstract][Full Text] [Related]
23. Rapid insulin-like growth factor-1-induced changes in granulosa cell thrombospondin-1 expression in vitro.
McGray AJ; Gingerich T; Petrik JJ; LaMarre J
J Reprod Dev; 2011 Feb; 57(1):76-83. PubMed ID: 21422735
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
25. Presence of potential nickel-responsive element(s) in the mouse MTH1 promoter.
Liang R; Igarashi H; Tsuzuki T; Nakabeppu Y; Sekiguchi M; Kasprzak KS; Shiao YH
Ann Clin Lab Sci; 2001 Jan; 31(1):91-8. PubMed ID: 11314867
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.
Lawler J; Sunday M; Thibert V; Duquette M; George EL; Rayburn H; Hynes RO
J Clin Invest; 1998 Mar; 101(5):982-92. PubMed ID: 9486968
[TBL] [Abstract][Full Text] [Related]
27. Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.
Borsotti P; Ghilardi C; Ostano P; Silini A; Dossi R; Pinessi D; Foglieni C; Scatolini M; Lacal PM; Ferrari R; Moscatelli D; Sangalli F; D'Atri S; Giavazzi R; Bani MR; Chiorino G; Taraboletti G
Pigment Cell Melanoma Res; 2015 Jan; 28(1):73-81. PubMed ID: 25256553
[TBL] [Abstract][Full Text] [Related]
28. Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.
Pinessi D; Ostano P; Borsotti P; Bello E; Guffanti F; Bizzaro F; Frapolli R; Bani MR; Chiorino G; Taraboletti G; Resovi A
Connect Tissue Res; 2015; 56(5):355-63. PubMed ID: 25943461
[TBL] [Abstract][Full Text] [Related]
29. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.
Volpert OV; Pili R; Sikder HA; Nelius T; Zaichuk T; Morris C; Shiflett CB; Devlin MK; Conant K; Alani RM
Cancer Cell; 2002 Dec; 2(6):473-83. PubMed ID: 12498716
[TBL] [Abstract][Full Text] [Related]
30. Construction and activity assay of the activating transcription factor 3 reporter vector pATF/CRE-luc.
Xu JQ; Deng JL; Wu YS; Fu HY; Wang RH; Zhang J; Lu F; Zhao ZL
Acta Biochim Biophys Sin (Shanghai); 2006 Jan; 38(1):58-62. PubMed ID: 16395528
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1 is a transcriptional repression target of PRMT6.
Michaud-Levesque J; Richard S
J Biol Chem; 2009 Aug; 284(32):21338-46. PubMed ID: 19509293
[TBL] [Abstract][Full Text] [Related]
32. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells.
Rath GM; Schneider C; Dedieu S; Rothhut B; Soula-Rothhut M; Ghoneim C; Sid B; Morjani H; El Btaouri H; Martiny L
Biochim Biophys Acta; 2006 Oct; 1763(10):1125-34. PubMed ID: 16962673
[TBL] [Abstract][Full Text] [Related]
33. Antisense-mediated reduction in thrombospondin-1 expression reduces cell motility in malignant glioma cells.
Amagasaki K; Sasaki A; Kato G; Maeda S; Nukui H; Naganuma H
Int J Cancer; 2001 Nov; 94(4):508-12. PubMed ID: 11745436
[TBL] [Abstract][Full Text] [Related]
34. T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components.
Li SS; Ivanoff A; Bergström SE; Sandström A; Christensson B; van Nerven J; Holgersson J; Hauzenberger D; Arencibia I; Sundqvist KG
Eur J Immunol; 2002 Apr; 32(4):1069-79. PubMed ID: 11920574
[TBL] [Abstract][Full Text] [Related]
35. High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth.
Castle VP; Ou X; O'Rourke K; Dixit VM
J Biol Chem; 1993 Feb; 268(4):2899-903. PubMed ID: 8428963
[TBL] [Abstract][Full Text] [Related]
36. Loss of thrombospondin transcriptional activity in nickel-transformed cells.
Salnikow K; Cosentino S; Klein C; Costa M
Mol Cell Biol; 1994 Jan; 14(1):851-8. PubMed ID: 8264652
[TBL] [Abstract][Full Text] [Related]
37. H-Ras increases release of sphingosine resulting in down-regulation of TSP-1 in non-transformed cells.
Kalas W; Rybka J; Swiderek E; Ziolo E; Rybka W; Gamian A; Rak J; Strzadala L
Int J Exp Pathol; 2012 Jun; 93(3):202-9. PubMed ID: 22356213
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.
Zhao C; Isenberg JS; Popel AS
PLoS Comput Biol; 2017 Jan; 13(1):e1005272. PubMed ID: 28045898
[TBL] [Abstract][Full Text] [Related]
39. Expression of thrombospondin-1 gene mRNA and protein in the placenta in gestosis.
Ostankova YV; Klimovskaya YS; Gorskaya OA; Kolobov AV; Kvetnoi IM; Selkov SA; Sokolov DI
Bull Exp Biol Med; 2011 Jun; 151(2):215-8. PubMed ID: 22238753
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a nickel resistant mouse cell line.
Imbra RJ; Wang XW; Costa M
Biol Trace Elem Res; 1989; 21():97-103. PubMed ID: 2484637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
